Trial intelligence / Profile preview

Ferric carboxymaltose vs placebo in anaemic patients undergoing major open abdominal surgery

2012-002786-35Phase 3Completed

Sponsor
University College London
Start
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) and anaemia comparing Ferric carboxymaltose (Ferinject) with Placebo (2 arms). Primary endpoints: Peri-operative blood transfusion requirement and Change in haemoglobin levels. Started Sep 2012; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)anaemia

Beyond the preview

Go deeper on 2012-002786-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002786-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call